Previous Article | Next Article 
Journal of Virology, May 2000, p. 4448-4455, Vol. 74, No. 10
0022-538X/00/$04.00+0
The Human Immunodeficiency Virus Type 1 gp120 V2
Domain Mediates gp41-Independent Intersubunit Contacts
Rob J.
Center,1
Patricia L.
Earl,1
Jacob
Lebowitz,2,3
Peter
Schuck,2 and
Bernard
Moss1,*
Laboratory of Viral Diseases, National Institute of Allergy
and Infectious Diseases,1 and Molecular
Interactions Resource, Bioengineering and Physical Science Program,
Office of Research Services,2 National
Institutes of Health, Bethesda, Maryland 20892, and
Department of Microbiology, University of Alabama at
Birmingham, Birmingham, Alabama 352943
Received 18 November 1999/Accepted 11 February 2000
 |
ABSTRACT |
The envelope protein of human immunodeficiency virus type 1 HIV-1
undergoes proteolytic cleavage in the Golgi complex to produce subunits
designated gp120 and gp41, which remain noncovalently associated. While
gp41 has a well-characterized oligomeric structure, the maintenance of
gp41-independent gp120 intersubunit contacts remains a contentious
issue. Using recombinant vaccinia virus to achieve high-level
expression of gp120 in mammalian cells combined with gel filtration
analysis, we were able to isolate a discrete oligomeric form of gp120.
Oligomerization of gp120 occurred intracellularly between 30 and 120 min after synthesis. Analysis by sedimentation equilibrium
unequivocally identified the oligomeric species as a dimer. In order to
identify the domains involved in the intersubunit contact, we expressed
a series of gp120 proteins lacking various domains and assessed the
effects of mutation on oligomeric structure. Deletion of the V1 or V3
loops had little effect on the relative amounts of monomer and dimer in
comparison to wild-type gp120. In contrast, deletion of either all or
part of the V2 loop drastically reduced dimer formation, indicating
that this domain is required for intersubunit contact formation.
Consistent with this, the V2 loop of the dimer was less accessible than
that of the monomer to a specific monoclonal antibody. Previous studies
have shown that while the V2 loop is not an absolute requirement for
viral entry, the absence of this domain reduces viral resistance to neutralization by monoclonal antibodies or sera. We propose that the
quaternary structure of gp120 may contribute to resistance to
neutralization by limiting the exposure of conserved epitopes.
 |
INTRODUCTION |
The envelope (env) proteins of human
immunodeficiency virus type 1 (HIV-1) mediate viral entry and are the
primary targets of neutralizing antibodies. Following synthesis and
posttranslational modifications in the endoplasmic reticulum, including
N-linked glycosylation, disulfide bond formation, and oligomerization, the env protein precursor gp160 passes through the Golgi complex where
it is cleaved to form subunits designated gp120 and gp41 (11,
41). A noncovalently associated oligomeric gp120-gp41 complex is
transported to the surface of infected cells, where incorporation into
budding virions occurs. The binding of virion-associated or
infected-cell-associated gp120 to the CD4 receptor induces conformational changes that promote subsequent interaction with one of
a number of chemokine receptors (19, 46, 49). Movement of
the variable (V) loop structure V1/V2 following CD4 binding has been
shown to result in increased exposure of an antibody epitope which
overlaps with the chemokine receptor binding site (44, 52).
Receptor binding-induced env conformational changes are believed to
culminate in the exposure of the gp41 fusion peptide and its
repositioning toward the target cell prior to fusion of the membranes
of the infected cell or virion and the target cell (5, 14, 26,
48).
Despite numerous investigations, the oligomeric structure of the native
env protein is still poorly understood. It has been demonstrated that
an amphipathic
-helix within the N-terminal portion of the
gp41 segment mediates gp160 oligomerization (10, 30).
Analysis by sucrose gradient sedimentation and/or chemical cross-linking suggests that mammalian-cell-expressed gp160 exists as a
mixture of dimers and higher-order oligomers (6, 8, 35).
Scanning transmission electron microscopy also revealed a dimeric gp160
molecule (45). Following cleavage in the Golgi complex, the
gp41 subunit retains an oligomeric structure, with tetramer being the
highest-order oligomer observed (6, 29, 35). Crystal-derived
structures of bacterial-cell-expressed N- and C-terminal gp41 fragments
revealed that the molecular basis of oligomerization was a coiled coil
composed of the N-terminal
-helices (5, 48), although in
this case trimer was formed. The C-terminal helices were packed in
grooves on the outside of the coiled-coil core. This structural
arrangement is thought to mimic that which occurs after receptor
binding-induced activation and fusion with the target cell membrane.
While the role of the gp41 N-terminal
-helix in the oligomerization
of gp160 and gp41 is well established, the question of whether the
intersubunit contacts of gp120 are sufficient for it to adopt and
maintain an oligomeric structure independently of gp41 remains unclear.
Where gp120 was expressed in the absence of gp41, scanning transmission
electron microscopy data led to the suggestion that gp120 was solely
monomeric (45), and coimmunoprecipitation experiments
demonstrated that gp120 could not form hetero-oligomers with gp160
(30). Furthermore, a gp120 core protein (with deletions at
the C and N termini and of the V1, V2, and V3 domains) crystallized as
a monomer (18). In contrast, gp120 within gp120-gp41
complexes expressed on the cell or virion surface revealed an
oligomeric structure when analyzed by chemical cross-linking and/or
sucrose gradient sedimentation (8, 47). Cell
surface-expressed gp120 which had been shed into the medium has been
shown to have an oligomeric structure under some experimental
conditions (27) but not others (8). The
observation that oligomeric structure could be disrupted during
ultracentrifugation suggests that the interaction may be relatively
labile (8, 47). Subunit interactions have been inferred from
the differential reactivity of epitopes in cell surface-expressed env
versus purified soluble gp120. Reduced exposure of epitopes within the
V2, C1, C4, and C5 domains of cell surface-expressed gp120 has been
reported (24, 34, 37, 39). While it is likely that reduced
exposure of the C1 and C5 epitopes is due at least in part to the
involvement of these domains in association between gp120 and gp41
(16, 50), the occlusion of epitopes in other domains is
presumably caused by the close proximity of gp120 subunits within the
oligomeric gp120-gp41 complex. The V3 domain appears to be well exposed
in cell surface-expressed gp120 derived from T-cell-line-adapted
strains but less well exposed in gp120 derived from a macrophage-tropic
strain (24, 34, 39). Importantly, exposure of cell
surface-expressed gp120 epitopes more accurately predicts the
neutralizing activity of monoclonal antibodies (MAb) than the epitope
exposure of purified soluble gp120 (12, 28, 33, 34, 43),
although MAb binding may not always be sufficient for neutralization
(13, 40).
Here, we report on the isolation of a soluble oligomeric form of gp120
expressed in the absence of gp41 in mammalian cells. Intersubunit
association occurred intracellularly and was stable during repeated gel
filtration. Sedimentation equilibrium analysis demonstrated that dimer
was the predominant oligomeric species. Deletion mutants lacking all or
part of the V2 loop were deficient in the production of gp120 dimers,
suggesting a role for this domain in intersubunit contact formation.
The relative inaccessibility of the V2 loop of the dimer to a specific
MAb is consistent with this model.
 |
MATERIALS AND METHODS |
Recombinant vaccinia viruses.
The recombinant vaccinia virus
vPE50 was made by excising a SmaI/EcoRI fragment
containing the gp120 coding sequence (BH8 clone, IIIB/LAI strain)
(31) followed by a downstream stop codon (9) and
ligating it into the StuI/EcoRI sites of pSC59
(4). The resultant plasmid pPE50, which directs expression
of the gp120 gene from the strong synthetic early/late promoter, was
used to produce the recombinant vaccinia virus vPE50 by standard
techniques (7). In order to produce the vRC
V1 and
vRC
V3 or vRCwt viruses, the NdeI/AocI
fragments were excised from mutated or wild-type pSVIIIenv plasmids
(52) and used to replace the corresponding fragment in
pPE50. The resultant plasmids were used to produce recombinant vaccinia
viruses. The pSVIIIenv plasmid directs expression of the wild-type
HXBc2 env clone (IIIB/LAI strain), and the mutant derivatives direct
expression of HXBc2 env lacking amino acids Asn-136 to Lys-151 (
V1)
or Thr-303 to Ile-323 (
V3). In order to express gp120 with V2 loop
deletions, an overlap PCR strategy was employed. PCRs were performed
using Pfu polymerase (Stratagene, La Jolla, Calif.), pPE50
as template, and the following oligonucleotide primer pairs: reaction
1, 5'-GCTAAAGCATATGATACAGAGG (5' outer) and
5'-CAACTTGTAGAGCAGTTTTTTATCTC; reaction 2, 5'-CCATGTGTACATTGTACTGTGC (3' outer) and
5'-AACTGCTCTACAAGTTGTAACACC; reaction 3, 5' outer and
5'-CTATTGGTTCTTTCTGCACCTTACC, and reaction 4, 3' outer and 5'-GCAGAAAGAACCAATAGATAATGATAC. The products of these
reactions were purified from residual oligonucleotides by agarose gel
electrophoresis and band excision. The products from reactions 1 and 2 and reactions 3 and 4 were then used as templates in secondary
reactions with both 5' outer and 3' outer primers. The products of
these reactions were digested with NdeI and StuI
and ligated into the corresponding sites of pPE50 to produce pRC
V2
and pRC
V2T, respectively. The recombinant virus derived from these
plasmids directs the expression of gp120 lacking amino acids Phe-159 to
Leu-193 (
V2) or Tyr-173 to Ile-182 (
V2T). Mutations in all
plasmids used to produce recombinant vaccinia viruses were confirmed by
DNA sequencing.
Antibodies.
The MAbs T54 and D47 have been described
previously (42). T54 binds to a conformation-sensitive
V2-dependent epitope, while D47 recognizes a linear epitope within the
V3 loop.
HIV-1 env expression, purification, and gel filtration.
BS-C-1 cells were infected with recombinant vaccinia virus at a
multiplicity of infection (MOI) of 5 in 850-cm2 roller
bottles (108 cells per bottle). Cells were overlaid with
serum-free Opti-MEM (Gibco BRL, Grand Island, N.Y.) and incubated for
1.5 to 2 days at 37°C. After centrifugation to remove cellular
debris, the supernatant was adjusted to 0.2% Triton X-100 in order to
reduce nonspecific binding and then allowed to pass over
lentil-lectin-Sepharose beads (Amersham Pharmacia Biotech AB, Uppsala,
Sweden) by gravity flow. After sequential washing with
phosphate-buffered saline (PBS) supplemented to 0.2% Triton X-100 and
an additional 300 mM NaCl and with PBS alone, glycoproteins were eluted
with PBS-0.5 M methyl-
-D-mannopyranoside and
concentrated using a Centriprep 30 (Amicon, Beverly, Mass.). The sample
(in a 1-ml volume) was subject to gel filtration chromatography using a
Superdex 200 column (Amersham Pharmacia Biotech AB) with PBS as the
buffer. A flow rate of 0.5 ml/min was used, and individual 1-ml
fractions of between 40 and 80 ml (total volume) were collected.
Immunoblotting and chemical cross-linking.
Proteins in
individual gel filtration fractions to be immunoblotted were subject to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
(10% gels) under reducing conditions and transferred to nitrocellulose
membranes. After blocking with 4% bovine serum albumin, membranes were
sequentially probed with a polyclonal rabbit serum raised against gp140
(for 2 h at room temperature in PBS-0.2% Tween 20) and iodinated
protein A (Amersham Pharmacia Biotech AB) (1 h at room temperature in
PBS-0.2% Tween 20), with washing between incubations. Signal was
revealed and quantitated by phosphor screen autoradiography using a
scanner and Imagequant software (Molecular Dynamics, Sunnyvale,
Calif.). Proteins to be cross-linked were incubated in the presence of ethylene glycol-bis(succinimidylsuccinate) (EGS; Pierce, Rockford, Ill.) at a final concentration of 5 mM for 30 min at room temperature and then quenched by adjusting the samples to 100 mM glycine and incubating them for a further 15 min prior to SDS-PAGE (6% gels) and immunoblotting.
Metabolic labeling, pulse-chase analysis, and sucrose gradient
sedimentation.
Prior to metabolic labeling, three tissue culture
wells with 106 BS-C-1 cells each were infected with the
recombinant vaccinia virus vPE50 at an MOI of 10 for 2 h. After a
further 3 h, the cells were incubated in methionine free Eagle
minimal essential medium (EMEM) for 30 min, followed by incubation in
methionine-free EMEM with the addition of 300 µCi of
[35S]methionine (NEN, Boston, Mass.) for 15 min. After
being washed with PBS, the cells in one well were immediately lysed in
PBS-1% Triton X-100 (pulse). Cells in the other two wells were washed in PBS and overlaid with EMEM-10% fetal bovine serum. After either 30 min or 2 h, these cells were lysed as before. Cell lysates were
loaded onto 5 to 20% sucrose gradients and centrifuged at 40,000 rpm
for 20 h at 4°C. Gradients were fractionated, and each 0.5-ml
fraction was precleared by the addition of nonimmune rabbit sera and
protein A-Sepharose (Amersham Pharmacia Biotech AB) with overnight
incubation at 4°C. Following the removal of the protein A-Sepharose,
labeled gp120 was immunoprecipitated by the addition of polyclonal
rabbit sera raised against gp140 and fresh protein A-Sepharose with
overnight incubation at 4°C. After the protein A-Sepharose beads were
washed with wash buffer (300 mM NaCl, 50 mM Tris [pH 7.4], 0.1%
Triton X-100, 0.02% azide), bound proteins were subjected to SDS-PAGE
(10%) as described above. Gels were dried, and the signal was revealed
and quantified by using phosphor screen autoradiography.
Sedimentation equilibrium and velocity measurements.
Sedimentation equilibrium was used to determine the molecular mass of
the monomeric and oligomeric forms of gp120. Sedimentation equilibrium
analysis was performed in the XL-A analytical ultracentrifuge using a
four-cell An-60 Ti rotor. In separate experiments, absorbance values
versus radial position data were obtained at 11,000 and 15,000 rpm at
10°C for the gp120 monomer fraction and at 7,600, 9,600, and 11,600 rpm at 10°C for the gp120 oligomer fraction. Scans were obtained at
280 nm at radial increments of 0.001 cm, with each datum point
representing the average of 10 repeats. The gp120 sedimentation
equilibrium data were considered as a heterogeneous system, since the
monomer and oligomer gel filtration fractions likely contained some
oligomers and monomers, respectively. This system was modeled by global
nonlinear regression fitting of the five data sets (for a review, see
reference 20). This was accomplished using a
two-species monomer and oligomer model. The variables determined by the
computational fitting are the molecular weight of the monomer, which
also determines the oligomer value, and the respective concentrations
of the monomer and oligomer at a selected reference position. The total
concentration of each component was calculated by integration of the
monomer and oligomer exponential functions. Goodness-of-fit was
determined from the residuals. The computational analysis was performed
by using the commercial software package MLAB (Civilized Software,
Bethesda, Md.).
Band sedimentation velocity was used to determine the sedimentation
coefficients of the gp120 monomeric and oligomeric forms (21). Measurements were made using a Beckman Instruments
XL-A analytical ultracentrifuge and a sample sector solution of 50% by
volume D2O-H2O containing PBS. The band
centerpiece was filled with 20 to 25 µl of gp120 monomer or oligomer
solution in PBS (protein concentration, 0.10 to 0.20 mg/ml).
Centrifugation was performed at 48,000 rpm with absorbance scanning at
230 nm. The Windows program Sedband (J. Lebowitz, P. Schuck, S. R. Kar,
G. Howlett, and R. W. Ott, unpublished data) was used for the
determination of band sedimentation coefficients. This program globally
fits the absorbance band profiles using a Gaussian model. Experimental s values were corrected to s20,w
values using the standard correction equation (20). The
relative viscosity and density values for 50% D2O-PBS are
1.1417 and 1.0593 as determined by direct viscometric measurement and
the use of a Paar density meter, respectively. The partial specific
volume value of gp120 was estimated by using the analysis of
glycoproteins developed by Lewis and Junghans (23). The
molecular mass of the peak of the mass distribution as determined by
mass spectral analysis of gp120 was 92 kDa (P. Earl and K. Parker,
unpublished data). This value allows calculation of the weight fraction
of protein (0.575) and carbohydrate (0.425), and the sum of each weight
fraction times the respective vbar values for
the protein and carbohydrate component (vbar,p
and vbar,c) allows for the calculation of a
range of vbar,gp values for gp120. A
protein vbar,p of 0.730 was determined from
amino acid composition. The Sednterp program 1.01 (http://www.bbri.harvard.edu/rasmb/rasmb.html) was used to
perform hydrodynamic modeling of gp120.
 |
RESULTS |
gp120 intersubunit contacts are sufficient to form stable
oligomers.
In order to assess the quaternary structure of gp120, a
recombinant form of this protein lacking the gp41 domain was expressed in mammalian cells by using a vaccinia virus vector. Glycoproteins present in the serum-free medium were purified by lentil-lectin affinity chromatography at physiological pH and then analyzed by gel
filtration. Two major protein peaks at 58.5 and 66 ml were resolved
(Fig. 1A). Immunoblotting with an
env-specific antiserum confirmed that peaks observed on the UV trace
contained gp120 (Fig. 1B). Moreover, SDS-PAGE followed by Coomassie
blue staining (data not shown) indicated the absence of significant
levels of contaminating protein in the peak fractions. Treatment with
the nonreducible cross-linker EGS was used to reveal the oligomeric state of gp120. gp120 from fractions corresponding to the more slowly
eluting peak (65 to 69 ml) showed limited propensity to cross-link with
EGS, mostly migrating during SDS-PAGE to a position consistent with
that expected for monomer, between the 105- and 160-kDa standards (Fig.
1C). In contrast, gp120 from fractions corresponding to the more
rapidly eluting peak (57 to 62 ml) migrated as a broad band overlapping
the 250-kDa standard, with little or no monomer present. The gp120 in
the 55- and 56-ml fractions appeared to migrate to a position above the
250-kDa standard after cross-linking, suggesting the possible presence
of a higher-order species. These results demonstrated that gp120
expressed in the absence of gp41 attained quaternary structure.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Gel filtration analysis of secreted gp120. B-SC-1 cells
were infected with a recombinant vaccinia virus encoding gp120 (vPE50).
Secreted gp120 was purified by lentil-lectin affinity chromatography
and analyzed by gel filtration over Superdex 200. (A) UV trace of gel
filtration experiment. The molecular radius standards were given by:
ferritin, F, 61.0 Å; catalase C, 52.2 Å; aldolase A, 48.1 Å; and
bovine serum albumin, B, 35.5 Å. Void volume
(Vo) was given by blue dextran 2000. (B)
Aliquots of 1-ml gel filtration fractions were analyzed by SDS-PAGE
(10% gel) and immunoblotting with env-specific antiserum. (C) Samples
as in panel B but treated with 5 mM EGS prior to SDS-PAGE (6% gel). In
panels B and C, the numbers on the right represent the positions and
masses (in kilodaltons) of marker proteins.
|
|
We sought to determine whether the gel filtration peaks represented
distinct gp120 species or, alternatively, were products of an
equilibrium reaction between associated and nonassociated states. In
order to distinguish between these possibilities, individual fractions
corresponding to the two gel filtration peaks were identified by
quantitation of an immunoblot probed with an env-specific antiserum (Fig. 2A). Fractions 59 to 61 and 66 to
68 (indicated by the bars) were separately pooled, concentrated, and
subjected to repeat gel filtration. Aliquots of fractions from these
experiments were immunoblotted with a specific antiserum as before.
Quantitation values of repeat gel filtration of the more slowly and
more rapidly eluting peaks are shown in Fig. 2B and C, respectively. In
both cases, a single peak was observed, with elution volumes
corresponding to the original pooled fractions (Fig. 2A). This result
demonstrated that gp120 intersubunit contacts were stably maintained
but not formed during gel filtration, indicating that the two peaks
observed represent distinct forms of the protein present in the sample prior to gel filtration.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Repeat gel filtration of secreted gp120. (A) Signal
quantitation of immunoblotted gel filtration fractions. Bars indicate
the fractions that were pooled and concentrated prior to repeat gel
filtration. (B) Signal quantitation of fractions from repeat gel
filtration of pooled monomer. (C) Signal quantitation of fractions from
repeat gel filtration of pooled oligomer. Note that panel A is derived
from the immunoblot displayed in Fig. 1B.
|
|
gp120 oligomers form intracellularly.
To determine if gp120
intersubunit contacts were made within the cell prior to secretion,
recombinant virus-infected BS-C-1 cells were metabolically labeled for
15 min, and intersubunit contact formation within cells was assessed at
subsequent time points by subjecting cell lysates to sucrose gradient
sedimentation. The latter procedure was used rather than gel filtration
because of the small sample sizes used for metabolic labeling.
Preliminary work showed that gp120 which sedimented on gradients to a
position between 7.3S and 11.3S could be chemically cross-linked,
whereas gp120 which sedimented between 4.4S and 7.3S remained monomeric after the same treatment (data not shown). When cells were lysed immediately after the pulse or after a chase period of 30 min, most
gp120 sedimented to fractions 17 to 19, which fell between the 4.4S and
7.3S sedimentation calibration standards (Fig.
3). Following a 120-min chase period, a
bimodal distribution of gp120 molecules across the gradient was
observed (Fig. 3). Along with the material sedimenting to fractions 17 to 19, a portion of the gp120 molecules sedimented to fractions 12 and
13 (between 7.3S and 11.3S). Therefore, the acquisition of intersubunit
contacts that were stable during sedimentation occurred within the
cells between 30 and 120 min after synthesis.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Intracellular gp120 oligomer formation. B-SC-1 cells
were infected with a recombinant vaccinia virus encoding gp120 (vPE50),
metabolically labeled for 15 min, and then lysed immediately (upper
panel) or chased for 30 or 120 min prior to lysis (middle and lower
panels, respectively). Lysates were sedimented through sucrose density
gradients, and gp120 from gradient fractions was immunoprecipitated
with an env-specific antiserum and subjected to SDS-PAGE (10% gels).
The direction of sedimentation was right to left. Gradients were
calibrated with catalase (11.3S), aldolase (7.3S), and bovine serum
albumin (4.4S).
|
|
gp120 self-associates mainly as a dimer.
The name given to
gp120 reflects its relative mobility during SDS-PAGE rather than its
true mass. A mass of 89 kDa was determined by scanning transmission
electron microscopy (45), and a mass of 92 kDa was
determined by mass spectroscopy (P. Earl and K. Parker, unpublished
data). Using the gel filtration standards noted above to calibrate the
elution profile shown in Fig. 1A, we calculated the molecular radii of
monomeric and oligomeric gp120 to be 49.9 and 62.3 Å, respectively.
These values suggest nonglobular shapes for both the monomeric and
oligomeric species, precluding the accurate determination of molecular
masses by this method. We therefore chose to use sedimentation
equilibrium analysis for oligomer mass determination. This technique
provides a rigorous analytical methodology for determining molecular
masses of proteins and protein complexes independent of shape. In order
to minimize cross-contamination of the two gp120 species, protein from
peak fractions of the repeat gel filtration experiments (Fig. 2B and C)
were used for sedimentation equilibrium. Fractions 59 to 62 and 66 to
69 of the repeat gel filtration of oligomeric and monomeric gp120
respectively were separately pooled and concentrated to approximately 1 mg/ml. Sedimentation equilibrium data were obtained for both the gp120
monomer and oligomer. Initial single component modeling of the
sedimentation equilibrium data using the separate monomer and oligomer
data indicated that the gp120 oligomer was a dimer (results not shown).
Modeling by two exponentials (monomer component and putative dimer
component) using global nonlinear regression fitting of the five data
sets is displayed in Fig. 4. To determine
the molecular weight from the fitting analysis, evaluation of the
partial specific volume of gp120 was required. Lewis and Junghans
(23) determined that the vbar,c of
the carbohydrate component of most substituted glycoproteins was in the
range of 0.602 to 0.642 ml/g. Selecting the midpoint of this
vbar,c range, we calculated a gp120
vbar,gp value of 0.684 ml/g, which when incorporated into the fitting model gave best-fit molecular weights of
92,490 ± 1,445 for the monomer and a corresponding doubling for
the dimer. The residuals of the fit were small and randomly distributed, strongly supporting the heterogeneous monomer and dimer
model. To further assess the validity of the model, we transformed the
highest centrifugal speed exponential data to a linear plot in each
sedimentation equilibrium data set. A linear plot of the exponential
data readily allows comparison of the best fit using a monomer, dimer,
or trimer model for the predominant gp120 form under analysis. For
dimer (Fig. 4, upper panel inset), the expected dimer line closely fits
to the experimental data, whereas neither the lower sloping line
expected for monomer nor the higher sloping line expected for trimer
fit the experimental results. In the case of monomer (Fig. 4, middle
panel inset), the expected monomer line closely fits to the
experimental line, whereas neither the dimer nor the trimer lines fit
the experimental results. Overall, the sedimentation equilibrium
results demonstrate that the higher-order oligomer of gp120 is
predominantly dimeric.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
Sedimentation equilibrium concentration profiles for the
dimer fraction (top panel) and for the monomer fraction (middle panel).
Rotor speeds were 7,600 ( ), 9,600 ( ), and 11,600 ( ) rpm for
the dimer fraction and 11,000 (+) and 15,00 (×) rpm for the monomer
fraction, respectively. Solid lines show the best-fit distributions
(root mean square error, 0.0078 optical density) after global modeling
with the monomer molecular weight and with the relative amounts of
monomer and dimer of each sample as unknowns. The best fit gave an
average molecular weight of 92,490 ± 1,445 for the monomer with a
corresponding doubling for the dimer. Residuals of the fitted lines to
the experimental data are shown in the lower panel. The calculated
absorbance contributions of the contaminating species are indicated by
dashed lines for the experiments at 11,600 and 15,000 rpm. Their
calculated relative total amounts were 5 ± 4% monomer
contamination of the dimer fraction and 27 ± 4% dimer
contamination of the monomer fraction. Incorporated in each
sedimentation equilibrium data panel is an inset in which the
highest-centrifugal-speed exponential data have been transformed into a
linear plot in the upper panel ( ) and the middle panel (×). This
transformation was achieved by subtracting the baseline offset first,
converting the x axis to a radius2 axis, and
then taking the derivative (dlnA/dr2) of the exponential
data. Solid lines of increasing slope for either a monomer, dimer, or
trimer model are given in order to compare the experimental data with
the best model for the quaternary state of the predominant gp120 form
under analysis.
|
|
Band sedimentation velocity analysis (analytical zone centrifugation)
produced s20,w values of 5.79S
(standard deviation [SD] = 0.0093) and 8.75S (SD = 0.013) for
monomeric and dimeric gp120, respectively (data not shown). If the
gp120 monomer and dimer were spherical in shape, the corresponding
s values would be 8.77S and 13.99S, respectively, using the
equation s = 0.012M2/3 (1
vbar,gp)/(vbar,gp)1/3.
The experimental-to-spherical frictional ratios
(f/fo = ssphere/s20,w) were 1.52 and 1.60 for the monomer and dimer samples, respectively. From the
frictional ratios the hydrodynamic shape asymmetry was evaluated using
a prolate ellipsoid as a model for gp120. The major (a)-to-minor (b)
axial ratio for the monomer is 9.59 (2a = 26 nm and 2b = 2.8 nm), and for the dimer the ratio was 11.1 (2a = 36.6 nm and
2b = 3.3 nm). These shape estimates did not include hydration and
consequently are the maximum asymmetry for the prolate model. Since the
monomer sample contains approximately 27% dimer, the measured
s20,w value was higher than the true
s20,w for a pure monomer, and
consequently the actual frictional ratio should be greater than that
cited above. However, for the dimer sample the fraction of monomer was
approximately 5%, and consequently the estimate of the shape asymmetry
was close to the true dimer value. This large asymmetry plus the
contribution from carbohydrate chains accounted for the errors in
molecular mass estimates based on size exclusion analysis from the gel
filtration data. Of importance from a molecular perspective, the gp120
dimer appears to be arranged as a side-to-side dimer based on the
frictional ratios.
The V2 loop is required for gp120 intersubunit association.
We
reasoned that intersubunit contacts would likely involve regions
exterior to the core of monomeric gp120. We focused on the variable
loop domains based on their presumed exterior placement (24,
51) and relatively modular nature as defined by the
disulfide-bonding pattern of gp120 (22). It has also been
shown that deletion of V1/V2 or V3 from IIIB/LAI strain-derived env
does not have a major impact on the global conformation of gp120, as
gauged by the ability to bind CD4 and associate with gp41
(53). The conformational intactness of all the mutants used
in this study was directly verified by their ability to interact with
sCD4 and conformation-dependent MAb to a C1 epitope and a complex
epitope not dependent on V1, V2, or V3 (data not shown). Accordingly, mutant gp120 lacking the V1, V2, or V3 domain was expressed, purified by lentil-lectin affinity chromatography, and subjected to gel filtration as before. Signal quantitation obtained from immunoblotted aliquots of gel filtration fractions are shown for wild-type gp120 and
for gp120 lacking V1, V3, or V2 (Fig. 5A,
B, C, and D, respectively). The two peaks corresponding to dimeric and
monomeric species were present in comparable amounts in wild-type gp120
and in gp120 lacking V1 or V3. In contrast, the profile of gp120
lacking V2 showed a marked reduction in the amount of gp120 in the more
rapidly eluting peak, indicating that this domain plays a major role in intersubunit association. In order to more precisely define the region
involved, a gp120 deletion mutant lacking amino acids Tyr-173 to
Ile-182 at the tip of the V2 loop was expressed as above. This region
contains a number of relatively conserved residues (17) and
is hydrophobic in nature, with Phe, Tyr, Leu, or Ile at 7 of 10 positions. When subjected to gel filtration, this mutant gp120 also
showed a marked reduction in intersubunit association (Fig. 5E),
although slightly more gp120 was seen in the more rapidly eluting peak
than was the case when the entire V2 domain was deleted. Overall,
analysis of the deletion mutants indicates that the V2 loop is required
for gp120 intersubunit association.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of variable domain deletion on gp120 oligomer
formation. B-SC-1 cells were infected with recombinant vaccinia virus
encoding wild-type or mutated gp120. Secreted gp120 was purified by
lentil-lectin affinity chromatography and analyzed by gel filtration
over Superdex 200. Aliquots of 1-ml fractions were immunoblotted with
an env-specific antiserum. Signal quantitation is shown for vRCwt (A),
vRC V1 (B), vRC V3 (C), vRC V2 (D), and vRC V2T (E). D and M
indicate the dimer and monomer, respectively.
|
|
An epitope within the V2 loop is occluded in dimeric gp120.
The data above are consistent with V2-V2 interactions or interactions
between the V2 domain of one subunit and a different domain of the
second subunit within the dimer. In order to evaluate these
possibilities, the exposure of a V2-specific MAb epitope was assessed
for both monomeric and dimeric gp120 by the immunoprecipitation of
metabolically labeled proteins. A V2-V2 interaction would be expected
to result in a more complete occlusion of this domain. The V3 loop has
been shown to be well exposed in cell surface-expressed gp120 derived
from T-cell-line-adapted strains (24, 34), and therefore
exposure of a V3-specific MAb epitope was also examined. The
V2-specific MAb epitope was markedly occluded within dimeric gp120
compared with monomer (Fig. 6). Signal
quantitation corrected for total amounts of monomer and dimer present,
as measured by immunoprecipitation with a polyclonal anti-env
antiserum, revealed that exposure of this V2-specific epitope was
approximately eightfold lower for dimeric gp120 compared with the
monomeric form. In contrast, the V3-specific epitope was shown to have
a similar level of exposure regardless of oligomeric status.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 6.
Comparison of epitope exposure of monomeric and dimeric
gp120. B-SC-1 cells were infected with a recombinant vaccinia virus
encoding gp120 (vPE50), metabolically labeled overnight, and lysed.
Lysates were sedimented through sucrose density gradients, and
fractions containing monomeric or dimeric gp120 were separately pooled.
Monomeric and dimeric gp120 were immunoprecipitated with env-specific
antiserum ( -env), the anti-V2 loop MAb T54 ( -V2), or the anti-V3
loop MAb D47 ( -V3).
|
|
 |
DISCUSSION |
We have shown that gp120 synthesized in the absence of gp41 can
form and maintain intersubunit contacts. Analysis of cell lysates
following pulse-labeling demonstrated that oligomers were formed
intracellularly between 30 and 120 min after synthesis. The fact that
secreted gp120 monomers did not form intersubunit contacts after
concentration indicates that dimerization occurs as part of the protein
folding process and that folding of the monomeric form is essentially
irreversible once complete. The dimer was stable to repeated gel
filtration as well as ultracentrifugation. Moreover, dissociation of
the dimer by SDS in the absence of reducing agent was inefficient.
However, treatment with 5.4 M guanidine hydrochloride prior to
nonreducing SDS-PAGE resulted in dissociation (data not shown).
Together, these data indicate that the intersubunit interactions are
noncovalent but that either prior treatment with a strong denaturant or
reduction of intramolecular disulfide bonds together with SDS treatment
are required for efficient dissociation. Dimerization was not unique to
one specific env protein, since gel filtration analysis of gp120
derived from the primary HIV-1 strain CM235 also suggested the
existence of higher-order oligomers (P. Earl, unpublished data). A
number of previous studies failed to detect appreciable amounts of
oligomeric gp120 following the loss of association with gp41 (8,
47) or when synthesis occurred in the absence of the gp41
oligomerization domain (10). These studies used sucrose
gradient sedimentation to gauge quaternary structure. We found in
preliminary experiments that gp120 oligomers were less well maintained
during this procedure than during gel filtration. Furthermore,
differences in the conditions used in this and previous studies,
including the detergent present, may have influenced the level of gp120
quaternary structure observed (27). In a study in which
gp160 and gp120 were coexpressed, it was found that no hetero-oligomers
were produced (30), indicating an absence of interaction
between gp120 and the gp120 moiety of gp160. This may have been due to
differences in the conformation of gp120 sequences within gp160 prior
to cleavage or to lower intracellular concentrations of gp120 in the
previous study compared with those obtained here. It is likely that
high expression levels of gp120 may be required for efficient
intersubunit contact formation given the fact that in the absence of
the gp41 subunit the protein is not membrane bound.
Sedimentation equilibrium analysis indicated that the more rapidly
eluting gel filtration peak was comprised mainly of gp120 dimers. A
dimeric form of HIV-1 envelope is consistent with reports of gp160
dimers observed using sucrose density gradients and chemical cross-linking (6, 8) or scanning transmission electron
microscopy (45). Furthermore, a soluble form of env
containing the gp41 N-terminal oligomerization domain (gp140) was found
using methods described here to be a mixture of dimers and tetramers
(P. Earl and J. Lebowitz, unpublished data). Mixing N- and C-terminal
transmembrane subunit fragments of HIV-1 (gp41) or HIV-2 which were
derived by synthetic peptide synthesis or bacterial-cell expression led to trimer formation. Crystal-derived structures showed that the oligomeric interface consisted of a coiled-coil interaction between the
N-terminal
-helical domains of each subunit (5, 48). It
seems unlikely that gp120 and gp41 on the cell surface would self-associate with different numbers of subunits. To accommodate a
trimeric structure for gp120 from our data it would be necessary to
propose that the interaction between two of the subunits is stronger
and therefore more stable during isolation and purification. This would
imply that the contacts between the three subunits are asymmetrical.
The NC1 domain of collagen type X presents an example of a highly
stable dimeric component of a trimeric protein (2).
Alternatively, it is possible that either the presence of gp120
modulates the oligomeric conformation adopted by the gp41 coiled coil
or vice versa. The potential conformational flexibility of coiled-coil
domains is demonstrated by the ability of a GCN4 leucine-zipper mutant
to adopt both dimeric and trimeric forms (15). A further
possibility is that the structural rearrangement that occurs in the
transition from the native to the fusion-activated or postfusion
conformation (mimicked by the mixed N- and C-terminal transmembrane
subunit fragments) includes a change in oligomeric valency. The
envelope protein E of the flavivirus tick-borne encephalitis virus
provides an example of a dimer-to-trimer transition induced by lowered
pH, which is believed to induce fusion of viral and endosomal membranes
(1).
Analysis of deletion mutants indicated that the V2 domain was required
for intersubunit contact formation. Deletion of the entire V1 or V3
domain had little impact on intersubunit association as assessed by gel
filtration, whereas deletion of the entire V2 domain largely eliminated
gp120 dimer formation and/or stability. Deletion of a conserved and
hydrophobic segment at the tip of the V2 domain (amino acids Tyr-173 to
Ile-182) also resulted in substantially less gp120 dimer, suggesting
that residues within this segment form part of the intersubunit contact
site. However, the possibility that the deletion of this segment
affects the local V2 conformation and inhibits intersubunit association
indirectly cannot be ruled out. We intend to perform further mutational
analysis to more precisely define the amino acids directly involved in association. The fact that a V2-specific MAb epitope was eightfold less
well exposed in dimeric gp120 compared with monomer suggests that the
intersubunit contact involves the interaction of the V2 domains of both
subunits within the dimer. It has been hypothesized that the ability of
a peptide based on the sequence of a second conserved domain segment of
gp120 to block the formation of gp120 oligomers (as assessed by gel
filtration) demonstrated the involvement of this domain in gp120
oligomer formation (36). While this does not conflict with
our findings, we point out that the latter study examined the
self-association of purified gp120, which was dependent on high
concentrations of calcium, and therefore may not reflect the
intracellular process which produces functional cell or virion
surface-expressed env. Furthermore, the involvement of the variable
loops in gp120 intersubunit association is consistent with the
crystallization of a gp120 molecule lacking these domains as a monomer
(18).
An involvement of the V2 loop in the gp120 intersubunit contact site is
also consistent with a number of reports suggesting that epitopes
within this domain are less accessible to MAb binding to cell
surface-expressed versus soluble purified gp120 (34, 37,
39). Moreover, it has also been shown that sera from infected individuals have few antibodies against V1/V2 epitopes (25). Within the V2 domain, it appears that epitopes located at the tip of
the loop are relatively more occluded in cell surface-expressed gp120
than those in the N-terminal flank (37), supporting the role
of the tip segment in association. The relative occlusion of a
V2-specific epitope in dimeric versus monomeric gp120, together with
the equal exposure of a V3-specific epitope irrespective of oligomeric
status observed in this study, is in accord with the epitope exposure
pattern reported for cell surface-expressed gp120 derived from
T-cell-line-adapted strains (34, 37). This is consistent
with a similar oligomeric organization for purified dimeric gp120 and
gp120 within gp120-gp41 complexes. A more complete study of epitope
exposure in dimeric and monomeric gp120 is being performed and will be
reported elsewhere. It is well established that MAb binding to cell
surface-expressed gp120 is more predictive of neutralization than is
binding to purified soluble gp120 (12, 28, 33, 34, 43). It
therefore seems likely that the quaternary structure of gp120
contributes to resistance to neutralization by limiting the exposure of
potentially neutralizing epitopes. This is supported by the finding
that removal of the V2 loop does not abrogate viral entry but can
markedly increase viral sensitivity to neutralization by MAbs or
patient sera (3, 38). Epitopes which are induced by CD4
binding and form part of the chemokine receptor binding site (18,
32) may be among those occluded at least in part by gp120
intersubunit association. Occlusion of CD4-induced epitopes of both
purified soluble or cell surface-expressed gp120 prior to CD4 binding
is substantially diminished upon deletion of the V1/V2 domain (44,
52).
In summary, we have shown that gp120 expressed in the absence of gp41
can form and maintain intersubunit contacts within cells, leading to
the secretion of stable dimers. Furthermore, an important determinant
of this association lies within the V2 domain. There is good evidence
that the quarternary structure of gp120 on the cell surface modulates
viral sensitivity to neutralization by antibody and probably influences
processes such as cell surface-receptor binding and the induction of
the conformational changes that culminate in fusion. Further
elaboration of the quaternary structure of gp120 may allow a greater
understanding of these processes than that gained by the study of
monomeric forms of this protein.
 |
ACKNOWLEDGMENTS |
We thank J. Sodroski for providing the pSVIIIenv plasmid and
mutant derivatives and N. Cooper for cells. Density and viscosity measurements for band sedimentation were performed by M. Vaske and M. Lewis, Molecular Interactions Resource, Office of Research Services,
National Institutes of Health.
R.J.C. was supported by C. J. Martin Fellowship 987004 provided by
the National Health & Medical Research Council of Australia.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Viral Diseases, National Institutes of Health, Bldg. 4, Rm. 229, 9000 Rockville Pike, Bethesda, MD 20892. Phone: (301) 496-9869. Fax: (301)
480-1147. E-mail: bmoss{at}nih.gov.
 |
REFERENCES |
| 1.
|
Allison, S. L.,
J. Schalich,
K. Stiasny,
C. W. Mandl,
C. Kunz, and F. X. Heinz.
1995.
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.
J. Virol.
69:695-700[Abstract].
|
| 2.
|
Barber, R. E., and A. P. L. Kwan.
1996.
Partial characterization of the C-terminal non-collagenous domain (NC1) of collagen type X.
Biochem. J.
320:479-485.
|
| 3.
|
Cao, J.,
N. Sullivan,
E. Desjardin,
C. Parolin,
J. Robinson,
R. Wyatt, and J. Sodroski.
1997.
Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.
J. Virol.
71:9808-9812[Abstract].
|
| 4.
|
Chakrabarti, S.,
J. R. Sisler, and B. Moss.
1997.
Compact, synthetic, vaccinia virus early/late promoter for protein expression.
BioTechniques
23:1094-1097[Medline].
|
| 5.
|
Chan, D. C.,
D. Fass,
J. M. Berger, and P. S. Kim.
1997.
Core structure of gp41 from the HIV envelope glycoprotein.
Cell
89:263-273[CrossRef][Medline].
|
| 6.
|
Doms, R. W.,
P. L. Earl, and B. Moss.
1991.
The assembly of the HIV-1 env glycoprotein into dimers and tetramers.
Adv. Exp. Med. Biol.
300:203-219[Medline].
|
| 7.
|
Earl, P. L.,
B. Moss,
L. S. Wyatt, and M. W. Carroll.
1998.
Generation of recombinant vaccinia viruses, p. 16.17.1-16.17.9.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
|
| 8.
|
Earl, P. L.,
R. W. Doms, and B. Moss.
1990.
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Proc. Natl. Acad. Sci. USA
87:648-652[Abstract/Free Full Text].
|
| 9.
|
Earl, P. L.,
S. Koenig, and B. Moss.
1991.
Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.
J. Virol.
65:31-41[Abstract/Free Full Text].
|
| 10.
|
Earl, P. L., and B. Moss.
1993.
Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein.
AIDS Res. Hum. Retrovir.
9:589-594[Medline].
|
| 11.
|
Earl, P. L.,
B. Moss, and R. W. Doms.
1991.
Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.
J. Virol.
65:2047-2055[Abstract/Free Full Text].
|
| 12.
|
Fouts, T. R.,
J. M. Binley,
A. Trkola,
J. E. Robinson, and J. P. Moore.
1997.
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.
J. Virol.
71:2779-2785[Abstract].
|
| 13.
|
Fouts, T. R.,
A. Trkola,
M. S. Fung, and J. P. Moore.
1998.
Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization.
AIDS Res. Hum. Retrovir.
14:591-597[Medline].
|
| 14.
|
Furuta, R. A.,
C. T. Wild,
Y. Weng, and C. D. Weiss.
1998.
Capture of an early fusion-active conformation of HIV-1 gp41.
Nat. Struct. Biol.
5:276-279[CrossRef][Medline].
|
| 15.
|
Gonzalez, L., Jr.,
R. A. Brown,
D. Richardson, and T. Alber.
1996.
Crystal structures of a single coiled-coil peptide in two oligomeric states reveal the basis for structural polymorphism.
Nat. Struct. Biol.
3:1002-1009[CrossRef][Medline].
|
| 16.
|
Helseth, E.,
U. Olshevsky,
C. Furman, and J. Sodroski.
1991.
Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein.
J. Virol.
65:2119-2123[Abstract/Free Full Text].
|
| 17.
|
Korber, B.,
C. Kuiken,
B. Foley,
B. Hahn,
F. McCutchan,
J. W. Mellors, and J. Sodroski.
1998.
Human retroviruses and AIDS 1998.
Los Alamos National Laboratory, Los Alamos, N. Mex.
|
| 18.
|
Kwong, P. D.,
R. Wyatt,
J. Robinson,
R. W. Sweet,
J. Sodroski, and W. A. Hendrickson.
1998.
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
Nature
393:648-659[CrossRef][Medline].
|
| 19.
|
Lapham, C. K.,
J. Ouyang,
B. Chandrasekhar,
N. Y. Nguyen,
D. S. Dimitrov, and H. Golding.
1996.
Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.
Science
274:602-605[Abstract/Free Full Text].
|
| 20.
|
Laue, T. M., and W. F. Stafford, III.
1999.
Modern applications of analytical ultracentrifugation.
Annu. Rev. Biophys. Biomol. Struct.
28:75-100[CrossRef][Medline].
|
| 21.
|
Lebowitz, J.,
M. Teale, and P. W. Schuck.
1998.
Analytical band centrifugation of proteins and protein complexes.
Biochem. Soc. Trans.
26:745-749[Medline].
|
| 22.
|
Leonard, C. K.,
M. W. Spellman,
L. Riddle,
R. J. Harris,
J. N. Thomas, and T. J. Gregory.
1990.
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
J. Biol. Chem.
265:10373-10382[Abstract/Free Full Text].
|
| 23.
| Lewis, M. S., and R. P. Junghans. A
strategy for ultracentrifugal analysis of the molecular mass of
glycoproteins of unknown or ill-defined carbohydrate composition.
Methods Enzymol., in press.
|
| 24.
|
Moore, J. P.,
Q. J. Sattentau,
R. Wyatt, and J. Sodroski.
1994.
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
J. Virol.
68:469-484[Abstract/Free Full Text].
|
| 25.
|
Moore, J. P.,
Q. J. Sattentau,
H. Yoshiyama,
M. Thali,
M. Charles,
N. Sullivan,
S.-W. Poon,
M. S. Fung,
F. Traincard,
M. Pinkus,
G. Robey,
J. E. Robinson,
D. D. Ho, and J. Sodroski.
1993.
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
J. Virol.
67:6136-6151[Abstract/Free Full Text].
|
| 26.
|
Muñoz-Barroso, I.,
S. Durell,
K. Sakaguchi,
E. Appella, and R. Blumenthal.
1998.
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
J. Cell Biol.
140:315-323[Abstract/Free Full Text].
|
| 27.
|
Owens, R. J., and R. W. Compans.
1990.
The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.
Virology
179:827-833[CrossRef][Medline].
|
| 28.
|
Parren, P. W. H. I.,
I. Mondor,
D. Naniche,
H. J. Ditzel,
P. J. Klasse,
D. R. Burton, and Q. J. Sattentau.
1998.
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
J. Virol.
72:3512-3519[Abstract/Free Full Text].
|
| 29.
|
Pinter, A.,
W. J. Honnen,
S. A. Tilley,
C. Bona,
H. Zaghouani,
M. K. Gorny, and S. Zolla-Pazner.
1989.
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
J. Virol.
63:2674-2679[Abstract/Free Full Text].
|
| 30.
|
Poumbourios, P.,
K. A. Wilson,
R. J. Center,
W. El Ahmar, and B. E. Kemp.
1997.
Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic -helical/leucine zipper-like sequence.
J. Virol.
71:2041-2049[Abstract].
|
| 31.
|
Ratner, L.,
W. Haseltine,
R. Patarca,
K. J. Livak,
B. Starcich,
S. F. Josephs,
E. R. Doran,
J. A. Rafalski,
E. A. Whitehorn,
K. Baumeister,
L. Ivanoff,
J. S. R. Petteway, Jr.,
M. L. Pearson,
J. A. Lautenberger,
T. S. Papas,
J. Ghrayeb,
N. T. Chang,
R. C. Gallo, and F. Wong-Staal.
1985.
Complete nucleotide sequence of the AIDS virus, HTLV-III.
Nature
313:277-284[CrossRef][Medline].
|
| 32.
|
Rizzuto, C. D.,
R. Wyatt,
N. Hernández-Ramos,
Y. Sun,
P. D. Kwong,
W. A. Hendrickson, and J. Sodroski.
1998.
A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.
Science
280:1949-1953[Abstract/Free Full Text].
|
| 33.
|
Roben, P.,
J. P. Moore,
M. Thali,
J. Sodroski,
C. F. Barbas III, and D. R. Burton.
1994.
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
J. Virol.
68:4821-4828[Abstract/Free Full Text].
|
| 34.
|
Sattentau, Q. J., and J. P. Moore.
1995.
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
J. Exp. Med.
182:185-196[Abstract/Free Full Text].
|
| 35.
|
Schawaller, M.,
G. E. Smith,
J. J. Skehel, and D. C. Wiley.
1989.
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.
Virology
172:367-369[CrossRef][Medline].
|
| 36.
|
Seddiki, N.,
H. Bouhlal,
L. Rabehi,
A. Benjouad,
C. Devaux,
J.-C. Gluckman, and L. Gattegno.
1997.
Involvement of the HIV-1 external envelope glycoprotein 120 (gp120) C2 region in gp120 oligomerization.
Biochim. Biophys. Acta
1340:277-282[CrossRef][Medline].
|
| 37.
|
Shotton, C.,
C. Arnold,
Q. Sattentau,
J. Sodroski, and J. A. McKeating.
1995.
Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.
J. Virol.
69:222-230[Abstract].
|
| 38.
|
Stamatatos, L., and C. Cheng-Mayer.
1998.
An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades.
J. Virol.
72:7840-7845[Abstract/Free Full Text].
|
| 39.
|
Stamatatos, L., and C. Cheng-Mayer.
1995.
Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding.
J. Virol.
69:6191-6198[Abstract].
|
| 40.
|
Stamatatos, L.,
S. Zolla-Pazner,
M. K. Gorny, and C. Cheng-Mayer.
1997.
Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Virology
229:360-369[CrossRef][Medline].
|
| 41.
|
Stein, B. S., and E. G. Engleman.
1990.
Intracellular processing of the gp160 HIV-1 envelope precursor.
J. Biol. Chem.
265:2640-2649[Abstract/Free Full Text].
|
| 42.
|
Sugiura, W.,
C. C. Broder,
B. Moss, and P. L. Earl.
1999.
Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with monomeric and oligomeric human immunodeficiency virus type 1 envelope proteins.
Virology
254:257-267[CrossRef][Medline].
|
| 43.
|
Sullivan, N.,
Y. Sun,
J. LI,
W. Hofmann, and J. Sodroski.
1995.
Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.
J. Virol.
69:4413-4422[Abstract].
|
| 44.
|
Sullivan, N.,
Y. Sun,
Q. Sattentau,
M. Thali,
D. Wu,
G. Denisova,
J. Gershoni,
J. Robinson,
J. Moore, and J. Sodroski.
1998.
CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization.
J. Virol.
72:4694-4703[Abstract/Free Full Text].
|
| 45.
|
Thomas, D. J.,
J. S. Wall,
J. F. Hainfeld,
M. Kaczorek,
F. P. Booy,
B. L. Trus,
F. A. Eiserling, and A. C. Steven.
1991.
gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains.
J. Virol.
65:3797-3803[Abstract/Free Full Text].
|
| 46.
|
Trkola, A.,
T. Dragic,
J. Arthos,
J. M. Biney,
W. C. Olson,
G. P. Allaway,
C. Cheng-Mayer,
J. Robinson,
P. J. Maddon, and J. P. Moore.
1996.
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Nature
384:184-187[CrossRef][Medline].
|
| 47.
|
Weiss, C. D.,
J. A. Levy, and J. M. White.
1990.
Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles.
J. Virol.
64:5674-5677[Abstract/Free Full Text].
|
| 48.
|
Weissenhorn, W.,
A. Dessen,
S. C. Harrison,
J. J. Skehel, and D. C. Wiley.
1997.
Atomic structure of the ectodomain from HIV-1 gp41.
Nature
387:426-430[CrossRef][Medline].
|
| 49.
|
Wu, L.,
N. P. Gerard,
R. Wyatt,
H. Choe,
C. Parolin,
N. Ruffing,
A. Borsetti,
A. A. Cardoso,
E. Desjardin,
W. Newman,
C. Gerard, and J. Sodroski.
1996.
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
Nature
384:179-183[CrossRef][Medline].
|
| 50.
|
Wyatt, R.,
E. Desjardin,
U. Olshevsky,
C. Nixon,
J. Binley,
V. Olshevsky, and J. Sodroski.
1997.
Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.
J. Virol.
71:9722-9731[Abstract].
|
| 51.
|
Wyatt, R.,
P. D. Kwong,
E. Desjardins,
R. W. Sweet,
J. Robinson,
W. A. Hendrickson, and J. G. Sodroski.
1998.
The antigenic structure of the HIV gp120 envelope glycoprotein.
Nature
393:705-711[CrossRef][Medline].
|
| 52.
|
Wyatt, R.,
J. Moore,
M. Accola,
E. Desjardin,
J. Robinson, and J. Sodroski.
1995.
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
J. Virol.
69:5723-5733[Abstract].
|
| 53.
|
Wyatt, R.,
N. Sullivan,
M. Thali,
H. Repke,
D. Ho,
J. Robinson,
M. Posner, and J. Sodroski.
1993.
Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
J. Virol.
67:4557-4565[Abstract/Free Full Text].
|
Journal of Virology, May 2000, p. 4448-4455, Vol. 74, No. 10
0022-538X/00/$04.00+0
This article has been cited by other articles:
-
Shibata, J., Yoshimura, K., Honda, A., Koito, A., Murakami, T., Matsushita, S.
(2007). Impact of V2 Mutations on Escape from a Potent Neutralizing Anti-V3 Monoclonal Antibody during In Vitro Selection of a Primary Human Immunodeficiency Virus Type 1 Isolate. J. Virol.
81: 3757-3768
[Abstract]
[Full Text]
-
Steckbeck, J. D., Orlov, I., Chow, A., Grieser, H., Miller, K., Bruno, J., Robinson, J. E., Montelaro, R. C., Cole, K. S.
(2005). Kinetic Rates of Antibody Binding Correlate with Neutralization Sensitivity of Variant Simian Immunodeficiency Virus Strains. J. Virol.
79: 12311-12320
[Abstract]
[Full Text]
-
Pancera, M., Lebowitz, J., Schon, A., Zhu, P., Freire, E., Kwong, P. D., Roux, K. H., Sodroski, J., Wyatt, R.
(2005). Soluble Mimetics of Human Immunodeficiency Virus Type 1 Viral Spikes Produced by Replacement of the Native Trimerization Domain with a Heterologous Trimerization Motif: Characterization and Ligand Binding Analysis. J. Virol.
79: 9954-9969
[Abstract]
[Full Text]
-
Bossart, K. N., Crameri, G., Dimitrov, A. S., Mungall, B. A., Feng, Y.-R., Patch, J. R., Choudhary, A., Wang, L.-F., Eaton, B. T., Broder, C. C.
(2005). Receptor Binding, Fusion Inhibition, and Induction of Cross-Reactive Neutralizing Antibodies by a Soluble G Glycoprotein of Hendra Virus. J. Virol.
79: 6690-6702
[Abstract]
[Full Text]
-
Gao, F., Weaver, E. A., Lu, Z., Li, Y., Liao, H.-X., Ma, B., Alam, S. M., Scearce, R. M., Sutherland, L. L., Yu, J.-S., Decker, J. M., Shaw, G. M., Montefiori, D. C., Korber, B. T., Hahn, B. H., Haynes, B. F.
(2005). Antigenicity and Immunogenicity of a Synthetic Human Immunodeficiency Virus Type 1 Group M Consensus Envelope Glycoprotein. J. Virol.
79: 1154-1163
[Abstract]
[Full Text]
-
Center, R. J., Lebowitz, J., Leapman, R. D., Moss, B.
(2004). Promoting Trimerization of Soluble Human Immunodeficiency Virus Type 1 (HIV-1) Env through the Use of HIV-1/Simian Immunodeficiency Virus Chimeras. J. Virol.
78: 2265-2276
[Abstract]
[Full Text]
-
Sailaja, G., Husain, S., Nayak, B. P., Jabbar, A. M.
(2003). Long-Term Maintenance of gp120-Specific Immune Responses by Genetic Vaccination with the HIV-1 Envelope Genes Linked to the Gene Encoding Flt-3 Ligand. J. Immunol.
170: 2496-2507
[Abstract]
[Full Text]
-
Lebowitz, J., Lewis, M. S., Schuck, P.
(2002). Modern analytical ultracentrifugation in protein science: A tutorial review. Protein Sci.
11: 2067-2079
[Abstract]
[Full Text]
-
Sanders, R. W., Vesanen, M., Schuelke, N., Master, A., Schiffner, L., Kalyanaraman, R., Paluch, M., Berkhout, B., Maddon, P. J., Olson, W. C., Lu, M., Moore, J. P.
(2002). Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1. J. Virol.
76: 8875-8889
[Abstract]
[Full Text]
-
Center, R. J., Leapman, R. D., Lebowitz, J., Arthur, L. O., Earl, P. L., Moss, B.
(2002). Oligomeric Structure of the Human Immunodeficiency Virus Type 1 Envelope Protein on the Virion Surface. J. Virol.
76: 7863-7867
[Abstract]
[Full Text]
-
Lewicki, D. N., Gallagher, T. M.
(2002). Quaternary Structure of Coronavirus Spikes in Complex with Carcinoembryonic Antigen-related Cell Adhesion Molecule Cellular Receptors. J. Biol. Chem.
277: 19727-19734
[Abstract]
[Full Text]
-
Hoffman, N. G., Seillier-Moiseiwitsch, F., Ahn, J., Walker, J. M., Swanstrom, R.
(2002). Variability in the Human Immunodeficiency Virus Type 1 gp120 Env Protein Linked to Phenotype-Associated Changes in the V3 Loop. J. Virol.
76: 3852-3864
[Abstract]
[Full Text]
-
Center, R. J., Schuck, P., Leapman, R. D., Arthur, L. O., Earl, P. L., Moss, B., Lebowitz, J.
(2001). Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation. Proc. Natl. Acad. Sci. USA
98: 14877-14882
[Abstract]
[Full Text]
-
Zhang, C. W-H., Chishti, Y., Hussey, R. E., Reinherz, E. L.
(2001). Expression, Purification, and Characterization of Recombinant HIV gp140. THE gp41 ECTODOMAIN OF HIV OR SIMIAN IMMUNODEFICIENCY VIRUS IS SUFFICIENT TO MAINTAIN THE RETROVIRAL ENVELOPE GLYCOPROTEIN AS A TRIMER. J. Biol. Chem.
276: 39577-39585
[Abstract]
[Full Text]
-
Esser, M. T., Bess, J. W. Jr., Suryanarayana, K., Chertova, E., Marti, D., Carrington, M., Arthur, L. O., Lifson, J. D.
(2001). Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1. J. Virol.
75: 1152-1164
[Abstract]
[Full Text]
-
Earl, P. L., Sugiura, W., Montefiori, D. C., Broder, C. C., Lee, S. A., Wild, C., Lifson, J., Moss, B.
(2001). Immunogenicity and Protective Efficacy of Oligomeric Human Immunodeficiency Virus Type 1 gp140. J. Virol.
75: 645-653
[Abstract]
[Full Text]
-
Salzwedel, K., Berger, E. A.
(2000). Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: Functional complementation of specific defects in gp120 and gp41. Proc. Natl. Acad. Sci. USA
10.1073/pnas.230438497v1
[Abstract]
[Full Text]
-
Staropoli, I., Chanel, C., Girard, M., Altmeyer, R.
(2000). Processing, Stability, and Receptor Binding Properties of Oligomeric Envelope Glycoprotein from a Primary HIV-1 Isolate. J. Biol. Chem.
275: 35137-35145
[Abstract]
[Full Text]
-
Salzwedel, K., Berger, E. A.
(2000). Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: Functional complementation of specific defects in gp120 and gp41. Proc. Natl. Acad. Sci. USA
97: 12794-12799
[Abstract]
[Full Text]